SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001479290-20-000026
Filing Date
2020-02-19
Accepted
2020-02-19 20:17:02
Documents
2
Period of Report
2020-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_158216140475336.html 3  
1 FORM 3 wf-form3_158216140475336.xml 3 1690
2 MOXIE POA ex-24.htm EX-24 3619
  Complete submission text file 0001479290-20-000026.txt   6613
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7555 GATEWAY BOULEVARD NEWARK CA 94560
Business Address
Moxie Dwight (Reporting) CIK: 0001803375 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36297 | Film No.: 20632130